858 Therapeutics, Inc.
1 clinical trials · Sponsor
◉ Watch 858 Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies (NCT06395519) | 858 Therapeutics, Inc. | 2024-05-13 |
Track 858 Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.